Quantres Asset Management’s Idexx Laboratories IDXX Stock Holding History

Quantres Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,300	Closed	-$360K	–	195
2017 Q4	$360K	Buy	2,300 +100	+5%	+$15.7K	0.23%	151
2017 Q3	$342K	Buy	2,200 +800	+57%	+$126K	0.22%	140
2017 Q2	$226K	Buy	+1,400	New	+$227K	0.15%	167

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Quantres Asset Management's IDXX Position: Q1 2018 in Review

Quantres Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2018, closing a stake of 2,300 shares — an estimated $360K sold.

Quantres Asset Management first reported a position in IDXX in Q2 2017 and held it in 3 quarters. The position peaked at $360K in Q4 2017. 645 funds tracked by Wall St. Rank hold IDXX as of Q1 2018.

Quantres Asset Management reported no remaining Idexx Laboratories position as of Q1 2018 after selling out during the quarter.
Quantres Asset Management sold 2,300 Idexx Laboratories shares in Q1 2018, an estimated $360K.
Quantres Asset Management first reported a position in Idexx Laboratories in Q2 2017 and held it in 3 quarters.
Quantres Asset Management's Idexx Laboratories position peaked at $360K in Q4 2017.
645 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2018.

Based on Quantres Asset Management's 13F filing for Q1 2018, filed 3 May 2018.